Found vs Willow: Which GLP-1 Provider Is Better?

By Iacob Pastina, Independent Researcher

48 providers verified independently·Independent research·How we rank →

Willow beats Found overall, scoring 8.2/10 vs 7.3/10. Found is more affordable at $264/mo vs $299/mo. Choose Found for users who want a science-backed weight loss program with beh. Choose Willow for users who want comprehensive clinical support with flexibili.

A side-by-side comparison of Found and Willow covering pricing, scores, medication types, insurance, and more to help you decide.

Found

#37 of 48

7.3/10

Science-backed weight management platform combining GLP-1 medications with behavioral health coaching and support.

Visit Found

Higher Rated

Willow

#8 of 48

8.2/10

Personalized GLP-1 weight loss with ongoing clinical support. Compounded semaglutide and tirzepatide only — Willow explicitly does not prescribe brand-name Wegovy or Zepbound. Added oral compounded semaglutide tablets as a non-injectable option.

Visit Willow

Feature	Found	Willow
Our Score	7.3/10	8.2/10
Starting Price	$264/mo	$299/mo
Medication Type	Both	Compounded
Insurance Accepted	Yes	No
Best For	Users who want a science-backed weight loss program with behavior change support	Users who want comprehensive clinical support with flexibility between injectable and oral compounded semaglutide routes
Ranking	#37	#8

Pros & Cons Compared

Found

Pros

+Active insurance coordination — Found contacts your insurer and reports which GLP-1s are covered, prior auth requirements, and estimated copay
+10+ medication options including both compounded and brand-name (Wegovy, Zepbound, Wegovy pill) — the widest formulary of any platform
+Typical insured copay of ~$30/mo for most members — dramatically lower than cash-pay alternatives
+Most members start treatment within one week of completing the health questionnaire

Cons

−Pricing is less transparent than flat-rate competitors — costs vary by insurance status and medication choice
−The insurance navigation process adds steps and complexity compared to simple cash-pay platforms
−Compounded medication availability may shift with FDA enforcement changes

Willow

Pros

+Includes monthly provider check-ins and dose adjustments at no extra cost
+Offers both injectable AND oral compounded semaglutide — one of few platforms with a daily oral tablet option
+$299/mo all-in for compounded semaglutide with monthly provider support
+90%+ patient retention rate after 3 months per their published outcomes data

Cons

−Compounded-only — no brand-name Wegovy or Zepbound through the platform
−Tirzepatide pricing reaches $499-$524 at higher doses — starting dose is $399/mo
−Cash-pay only — no insurance billing, though they provide superbills for FSA/HSA
−Founded in 2024 — less track record than Ro or Hims, though growth has been fast

Our Verdict

Willow edges out Found with a score of 8.2/10 vs 7.3/10. If budget is your priority, Found starts at $264/mo compared to Willow's $299/mo. Found accepts insurance, which can significantly reduce your out-of-pocket costs. Found offers both brand-name and compounded medications, giving you more flexibility. Choose Found if you want: users who want a science-backed weight loss program with behavior change support. Choose Willow if you want: users who want comprehensive clinical support with flexibility between injectable and oral compounded semaglutide routes.

Still undecided? Editor's #1 Overall Pick

Eden Health GLP-1

$249/mo · 8.9/10 · Both

If neither Found nor Willow feels like the right fit, our overall #1 pick across all 48 GLP-1 telehealth providers is Eden Health GLP-1 — strongest balance of clinical oversight, transparent pricing, and verified availability.

Visit Eden Health GLP-1→Read our full Eden Health GLP-1 review